Tumor Treating Fields: killing two birds with one stone

Given its aggressive natural history and immunosuppressive nature, glioblastoma (GBM) remains difficult to treat. Tumor Treating Fields (TTFields) are a promising treatment for GBM patients, yet the entirety of their antitumor action has not been fully elucidated. In a recent issue of the JCI, Chen...

Full description

Bibliographic Details
Main Authors: Juyeun Lee, Matthew M. Grabowski, Justin D. Lathia
Format: Article
Language:English
Published: American Society for Clinical Investigation 2022-04-01
Series:The Journal of Clinical Investigation
Online Access:https://doi.org/10.1172/JCI159073
_version_ 1818236577132838912
author Juyeun Lee
Matthew M. Grabowski
Justin D. Lathia
author_facet Juyeun Lee
Matthew M. Grabowski
Justin D. Lathia
author_sort Juyeun Lee
collection DOAJ
description Given its aggressive natural history and immunosuppressive nature, glioblastoma (GBM) remains difficult to treat. Tumor Treating Fields (TTFields) are a promising treatment for GBM patients, yet the entirety of their antitumor action has not been fully elucidated. In a recent issue of the JCI, Chen et al. explored the effect of TTFields in reinvigorating immune responses. By elegant step-by-step approaches, the authors demonstrated that TTFields promote the production of immune-stimulating proinflammatory and interferon type 1 cytokines in tumor cells in a cGAS/STING- and AIM2 inflammasome–dependent mechanism, thereby activating the immune system. The findings show that TTFields not only directly inhibit tumor cell growth, as previously reported, but enhance antitumor immunity, suggesting TTFields can be used as an immune-modulating approach in GBM.
first_indexed 2024-12-12T12:12:04Z
format Article
id doaj.art-d982ba042495419ea371a5bbf58f1062
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-12-12T12:12:04Z
publishDate 2022-04-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-d982ba042495419ea371a5bbf58f10622022-12-22T00:24:51ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382022-04-011328Tumor Treating Fields: killing two birds with one stoneJuyeun LeeMatthew M. GrabowskiJustin D. LathiaGiven its aggressive natural history and immunosuppressive nature, glioblastoma (GBM) remains difficult to treat. Tumor Treating Fields (TTFields) are a promising treatment for GBM patients, yet the entirety of their antitumor action has not been fully elucidated. In a recent issue of the JCI, Chen et al. explored the effect of TTFields in reinvigorating immune responses. By elegant step-by-step approaches, the authors demonstrated that TTFields promote the production of immune-stimulating proinflammatory and interferon type 1 cytokines in tumor cells in a cGAS/STING- and AIM2 inflammasome–dependent mechanism, thereby activating the immune system. The findings show that TTFields not only directly inhibit tumor cell growth, as previously reported, but enhance antitumor immunity, suggesting TTFields can be used as an immune-modulating approach in GBM.https://doi.org/10.1172/JCI159073
spellingShingle Juyeun Lee
Matthew M. Grabowski
Justin D. Lathia
Tumor Treating Fields: killing two birds with one stone
The Journal of Clinical Investigation
title Tumor Treating Fields: killing two birds with one stone
title_full Tumor Treating Fields: killing two birds with one stone
title_fullStr Tumor Treating Fields: killing two birds with one stone
title_full_unstemmed Tumor Treating Fields: killing two birds with one stone
title_short Tumor Treating Fields: killing two birds with one stone
title_sort tumor treating fields killing two birds with one stone
url https://doi.org/10.1172/JCI159073
work_keys_str_mv AT juyeunlee tumortreatingfieldskillingtwobirdswithonestone
AT matthewmgrabowski tumortreatingfieldskillingtwobirdswithonestone
AT justindlathia tumortreatingfieldskillingtwobirdswithonestone